FREES FUND: A venture capital firm investing in early and growth stage tech startups in China and the U.S.
Location
Beijing, CN
Founded
2015
FREES FUND is a venture capital firm specializing in early and growth stage investments in technology startups across China and the U.S. The firm typically participates in various funding rounds, including Seed, Series A, Series B, and Series C, with investment amounts ranging from $600,000 to $181 million. FREES FUND aims to support innovative companies that have the potential for significant long-term value creation.
Notable portfolio companies include Cider, Conflux Network, Covariant, Junoco, Mask Network, Metis Therapeutics, N1 Life, PatPat, Pingcap, Propel(X), Robby Technologies, Unity, Workrise, and XtalPi. The firm is led by key partners with extensive experience in the tech industry. FREES FUND emphasizes a hands-on investment philosophy, providing strategic guidance and leveraging its network to help portfolio companies scale effectively.
Frees Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
